- Home
- TONX vs LNSR Comparison
TONX vs LNSR Comparison
Compare TONX & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | LNSR |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | United States |
| Employees | 23 | N/A |
| Industry | Other Consumer Services | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.5M | 146.7M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | TONX | LNSR |
|---|---|---|
| Price | $2.68 | $5.79 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.50 |
| AVG Volume (30 Days) | ★ 361.6K | 160.2K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $53,494,000.00 |
| Revenue This Year | $526.82 | $19.55 |
| Revenue Next Year | $45.45 | $35.89 |
| P/E Ratio | $0.26 | ★ N/A |
| Revenue Growth | N/A | ★ 26.87 |
| 52 Week Low | $1.75 | $5.83 |
| 52 Week High | $8.23 | $14.27 |
Technical Indicators
Market Signals| Indicator | TONX | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 50.23 | 15.13 |
| Support Level | $1.80 | N/A |
| Resistance Level | $3.61 | $12.85 |
| Average True Range (ATR) | 0.29 | 0.62 |
| MACD | -0.02 | -0.60 |
| Stochastic Oscillator | 23.75 | 0.38 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.